GO
Loading...

Takeover Bids

More

  • *AstraZeneca slumps after rejecting "final" Pfizer bid. LONDON, May 19- European equities slid on Monday, pulled down by pharmaceuticals group AstraZeneca, which slumped after rejecting a Pfizer takeover bid, and by Deutsche Bank, where a capital increase weighed on bank stocks.

  • LONDON, May 19- British pharmaceuticals giant AstraZeneca faces a clash with its shareholders amid mounting disappointment at its rejection on Monday of a sweetened takeover offer by Pfizer.

  • LONDON, May 18- U.S. drugmaker Pfizer Inc is planning to raise its offer for AstraZeneca Plc as it works with its advisers against the clock in a battle where they have just eight days left to move under British takeover rules.

  • Clock ticking for Pfizer to raise AstraZeneca bid Sunday, 18 May 2014 | 8:30 AM ET

    LONDON, May 18- Pfizer is considering raising its offer for AstraZeneca as it works with its advisers against the clock in a battle where they have just eight days left to move under British takeover rules.

  • *Cancer drugs form central plank of AstraZeneca portfolio. May 15- New data showing an experimental AstraZeneca lung cancer drug shrank tumors in more than half of patients gave the British group fresh ammunition to argue that Pfizer's takeover offer undervalues it substantially.

  • *Analyst says could deter GE from bid for Alstom assets. PARIS, May 15- The French government gave itself the power to block foreign corporate takeovers in "strategic" sectors on Thursday, throwing up a potential roadblock to General Electric's $16.9 billion bid for Alstom's energy assets.

  • PARIS, May 15- The French government has issued a decree allowing it to block foreign takeovers of French firms in "strategic" sectors, throwing up a potential roadblock to General Electric's $16.9 billion bid for Alstom's energy assets.

  • May 15- New data showing an experimental AstraZeneca lung cancer drug shrank tumors in more than half of patients gives the British group fresh ammunition to argue that Pfizer's takeover offer undervalues it substantially. AstraZeneca believes it could sell as much as $3 billion a year.

  • PARIS, May 15- The French government has issued a decree allowing it to block foreign takeovers of French firms in "strategic" sectors, throwing up a potential roadblock to General Electric's $16.9 billion bid for Alstom's energy assets.

  • MELBOURNE/ HONG KONG, May 15- The days when Australian mining magnates could dictate terms to Chinese buyers are over. "This may get the wheels turning where other Chinese companies are sitting with big stakes and have an inside track," said Paul Donnelly, executive director at JPMorgan, who works on metals and mining deals.

  • May 13- Valeant Pharmaceuticals International Inc said on Tuesday it will sweeten its unsolicited $47 billion offer for drugmaker Allergan Inc, and activist shareholder Pershing Square Capital Management said it would ask for a non-binding vote to pressure Allergan to the negotiating table.

  • May 13- Valeant Pharmaceuticals International Inc said on Tuesday it will "improve" its unsolicited $47 billion takeover offer for drugmaker Allergan Inc, a day after the U.S. company rejected the bid.

  • UPDATE 1-Valeant plans to "improve" offer for Allergan Tuesday, 13 May 2014 | 8:43 AM ET

    May 13- Valeant Pharmaceuticals International Inc said on Tuesday it will "improve" its $47 billion takeover offer for drugmaker Allergan Inc, a day after the U.S. company rejected the bid. Allergan put in a so-called "poison pill" within days to slow Ackman from increasing his nearly 10 percent stake in Allergan.

  • Valeant says plans to "improve" offer for Allergan Tuesday, 13 May 2014 | 8:13 AM ET

    May 13- Valeant Pharmaceuticals International Inc said it planned to "improve" its $47 billion takeover offer for drugmaker Allergan Inc, a day after the U.S. company rejected the bid. Canada's Valeant said it remained committed to getting the deal done but would remain "financially disciplined."

  • *Over 90 pct of Scania shareholders accept buyout offer. HANOVER, Germany/ STOCKHOLM, May 13- Volkswagen's 6.7 billion euro offer for its Swedish trucks arm Scania has been accepted by minority shareholders, a big step in the German automaker's plan to create a trucks alliance to compete in global markets.

  • *Over 90 pct of Scania shareholders accepted buyout offer. HANOVER, Germany/ STOCKHOLM, May 13- Volkswagen's 6.7 billion euro offer for its Swedish truck division Scania was accepted by minority shareholders, a big step in the German automaker's plan to create a trucks alliance to compete in global markets.

  • *Guangdong already owns 23 percent of PanAust. *PanAust not recommending bid but allows due diligence. SYDNEY/ MELBOURNE, May 13- China's Guangdong Rising Assets Management has proposed a A $1.1 billion takeover offer for copper and gold miner PanAust Ltd, the second bid for an Australian resources firm by a Chinese state-owned company in two weeks.

  • *Allergan says offer undervalues company. *Allergan expects EPS growth of 20-25 percent. May 12- U.S. drugmaker Allergan Inc on Monday rejected Valeant Pharmaceuticals International Inc's $47 billion takeover offer, saying the suitor's proposed cost cuts were too steep.

  • Faber Report: Hillshire to acquire Pinnacle     Monday, 12 May 2014 | 10:16 AM ET

    CNBC's David Faber reports Hillshire Brands is buying Pinnacle Foods. And Faber comments on Allergan's rejection of Valeant's takeover bid.

  • What Cramer expects from IPO market     Monday, 12 May 2014 | 9:08 AM ET

    Allergan has rejected a $47 billion takeover bid by Valeant Pharmaceuticals. The "Squawk on the Street" news team discuss m&a in pharmaceuticals and the IPO market.